Other
Noncontrolling interests in subsidiaries
Thermo Fisher Scientific Noncontrolling interests in subsidiaries remained flat by 0.0% to $7M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 121.2%, from -$33M to $7M. Over 5 years (FY 2020 to FY 2025), Noncontrolling interests in subsidiaries shows a downward trend with a -6.9% CAGR.
Analysis
StatementBalance Sheet Statement
SectionOther
First reportedQ4 2020
Last reportedQ1 2026May 1, 2026
Metric ID:
other_minority_interestHistorical Data
18 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $62M | $62M | $61M | $59M | $54M | $53M | $50M | $18M | -$11M | -$12M | -$12M | -$20M | -$33M | -$33M | -$35M | $7M | $7M | $7M |
| QoQ Change | — | +0.0% | -1.6% | -3.3% | -8.5% | -1.9% | -5.7% | -64.0% | -161.1% | -9.1% | +0.0% | -66.7% | -65.0% | +0.0% | -6.1% | +120.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -12.9% | -14.5% | -18.0% | -69.5% | -120.4% | -122.6% | -124.0% | -211.1% | -200.0% | -175.0% | -191.7% | +135.0% | +121.2% | +121.2% |
Range-$35M – $62M
CAGR-40.1%
Avg YoY Growth-63.0%
Median YoY Growth-94.9%
Current Streak3 quarters growth
Noncontrolling interests in subsidiaries at Other Companies
Frequently Asked Questions
- What is Thermo Fisher Scientific's noncontrolling interests in subsidiaries?
- Thermo Fisher Scientific (TMO) reported noncontrolling interests in subsidiaries of $7M in Q1 2026.
- How has Thermo Fisher Scientific's noncontrolling interests in subsidiaries changed year-over-year?
- Thermo Fisher Scientific's noncontrolling interests in subsidiaries increased by 121.2% year-over-year, from -$33M to $7M.
- What is the long-term trend for Thermo Fisher Scientific's noncontrolling interests in subsidiaries?
- Over 5 years (2020 to 2025), Thermo Fisher Scientific's noncontrolling interests in subsidiaries has grown at a -6.9% compound annual growth rate (CAGR), from $10M to $7M.